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Catechol-O-methyl transferase (COMT) is involved in the inactivation of dopamine in brain 
regions in which the dopamine transporter (DAT1) is sparsely expressed.  The membrane-bound 
isoform of COMT (MB-COMT) is the predominantly expressed form in the mammalian central 
nervous system (CNS). It has been a matter of debate whether in neural cells of the CNS 
the enzymatic domain of MB-COMT is oriented toward the cytoplasmic or the extracellular 
compartment. Here we used live immunocytochemistry on cultured neocortical neurons and 
glial cells to investigate the expression and membrane orientation of native COMT and of 
transfected MB-COMT fused to green fluorescent protein (GFP). After live staining, COMT 
immunoreactivity was reliably detected in both neurons and glial cells after permeabilization, 
but not on unpermeabilized cells. Similarly, autofluorescence of COMT-GFP fusion protein 
and antibody fluorescence showed overlap only in permeabilized neurons. Our data provide 
converging evidence for an intracellular membrane orientation of MB-COMT in neurons and 
glial cells, suggesting the presence of a DAT1-independent postsynaptic uptake mechanism 
for dopamine, prior to its degradation via COMT.
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and genetic variations of COMT have been implicated in an increased 
individual risk for schizophrenia (Egan et al., 2001; for a review see 
Williams et al., 2007) and in PFC-dependent cognitive function in both 
healthy humans and patients with schizophrenia (Egan et al., 2001; 
Schott et al., 2006; Tan et al., 2007; Diaz-Asper et al., 2008).
DAT1-independent function of COMT would require either 
extracellular activity of the enzyme or a DAT1-independent cate-
cholamine uptake, which might be postsynaptic or glial (Tunbridge 
et al., 2006a). Previous studies have demonstrated that COMT is 
highly expressed in glial cells and also perisynaptically in neurons 
(Rivett et al., 1983b; Karhunen et al., 1995a; Matsumoto et al., 
2003). However, these studies do not provide information on the 
membrane orientation of the enzyme. As deduced from the pri-
mary structure, MB-COMT has a single hydrophobic region, which 
might act as an internal start-transfer sequence for non-cleaved 
signal anchor proteins. Different computer-assisted membrane 
topology prediction routines based on the classical von Heijne 
algorithms (Elofsson and von Heijne, 2007) lead to non-uniform 
predictions: either a type I transmembrane topology with the 
N-terminus extra- and the C-terminus intracellularly or a type 
II configuration with the opposite orientation. In non-neuronal 
cells heterologously expressing MB-COMT, COMT immunoreac-
tivity was only detectable after permeabilization of cells (Ulmanen 
et al., 1997). This study also suggested that COMT overexpressed 
in neurons using a viral expression system was primarily located 
at intracellular organelle membranes rather than at the plasma 
membrane. An electron microscopic study, however, did show that 
IntroductIon
Catechol-O-methyl transferase (COMT, EC_number 2.1.1.6) is 
involved in the degradation of dopamine and other catecholamines 
by transferring a methyl group donated by S-adenosyl-methionine 
onto a phenolic hydroxyl group. COMT is expressed in two iso-
forms, a soluble form (S-COMT), which is highly expressed in 
peripheral tissues, such as the liver, and a membrane-bound form 
(MB-COMT). MB-COMT is the predominantly expressed COMT 
isoform in the mammalian central nervous system (CNS; Rivett 
et al., 1983a, b; Reenilä and Männistö, 2001; Chen et al., 2004).
Converging evidence from animal studies and human post mor-
tem investigations raised the hypothesis that COMT is particularly 
important for dopamine inactivation when dopamine uptake by the 
presynaptic dopamine transporter (DAT1) is inhibited or in brain 
regions in which DAT1 is sparsely expressed, such as the prefrontal 
cortex (PFC; Karoum et al., 1994; Sesack et al., 1998; Matsumoto et al., 
2003). The pivotal role of COMT in the control of prefrontal dopamine 
levels has attracted considerable attention in neuropsychiatric research, 
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GeneratIon of coMt-GfP fusIon constructs, transfectIon, 
and cell fractIonatIon
Because  the  hydrophobic  peptide  that  putatively  functions  as 
a transmembrane domain in MB-COMT is located toward the 
N-terminus of the protein, green fluorescent protein (GFP) moie-
ties were fused to the C-terminus (Figure 4A). The cDNA of human 
MB-COMT and S-COMT was amplified from a fetal human cDNA 
library (Stratagene) using nested PCR and cloned into the EcoRI 
and BamHI restriction sites of the pEGFP-N1 eukaryotic expres-
sion vector (Clontech). The Met codon at amino acid position 51 
of human MB-COMT cDNA (NM_000754), which also serves as 
the start codon for S-COMT, was mutated to GTG (Val) or GCG 
(Ala), using PCR-based site-directed mutagenesis. Primers used 
for cloning and mutagenesis are displayed in Table 1. Mutated 
constructs  were  also  cloned  into  pEGFP-N1,  using  the  same 
restriction sites. The base sequences of the inserts and the flank-
ing regions of the vector were verified by custom sequencing into 
both directions (SeqLab).
To verify the correct expression of the COMT-GFP fusion con-
structs, COS7 cells were transfected with the constructs, using the 
PolyFect  transfection  reagent  (Qiagen,  Chatsworth,  CA,  USA) 
according to manufacturer’s protocols. After incubation at 37°C 
for 36 h, cells were visually inspected for green fluorescence, and 
harvested  in  Tris-buffered  saline  (TBS).  Protein  fractionation 
and  Western  blotting  were  conducted  as  described  previously 
(Seidenbecher  et  al.,  2002),  with  minor  modifications.  Briefly, 
cells were homogenized in TBS containing a protease inhibitor 
cocktail (Complete; Boehringer Mannheim, Germany) and cen-
trifuged at 12,000 g for 15 min (4°C). The supernatant was kept as 
cytosolic fraction (S1; including microsomes), and the pellet was re-
homogenized in TBS containing 1% Triton X-100 and centrifuged 
at 20,000 g for 15 min (4°C), yielding the S2 fraction containing 
detergent-soluble membrane proteins and the pellet (P) containing 
Triton-insoluble membrane or cytoskeletal proteins. All obtained 
protein fractions were solubilized with sodium dodecyl sulfate 
(SDS) and mercaptoethanol. The whole-cell homogenate and the 
fractionated proteins were separated by SDS-PAGE on 5–20% gels 
under fully reducing conditions and transferred onto nitrocellu-
lose according to standard protocols. Western blots were incubated 
overnight with the primary antibody, and processed using the ECL 
system according to the manufacturer’s protocol.
COMT immunoreactivity could be observed at the dendritic plasma 
membrane of parietal cortex neurons and was present at synaptic 
membranes (Karhunen et al., 1995b), but the orientation of the 
immunoreactive domain could not be resolved by that study.
On the other hand, microdialysis studies have provided evidence 
for high concentrations of COMT-dependent dopamine metabo-
lites in brain regions with low DAT1 expression or under condi-
tions of pharmacological DAT1 inhibition (Karoum et al., 1994; 
Huotari et al., 1999). Furthermore, the different temporal patterns 
of tonic and phasic dopamine action in the striatum and the PFC 
have been suggested to result, in part, from extracellular activity 
of COMT (Bilder et al., 2004). To provide better understanding of 
the relationship between dopamine action in the striatum and the 
PFC, it thus seems critical to elucidate the membrane orientation 
of COMT in the CNS (Tunbridge et al., 2006a).
Here, we used live staining of rat primary neural cultures to 
investigate the orientation of the MB-COMT catalytic domain in 
neurons and glial cells. Both, immunostaining of natively expressed 
COMT in cortical cultures, and co-localization studies of COMT-
GFP fusion constructs were performed.
MaterIals and Methods
antIbodIes
The rabbit anti-COMT polyclonal antibody (Chemicon, AB5873) 
was used at a concentration of 1:500. The rabbit polyclonal anti-GFP 
antibody (Abcam, ab6556) was used at concentrations of 1:5,000 
and 1:1,000 for Western blotting and immunocytochemistry, respec-
tively. Mouse monoclonal antibodies against microtubule-associated 
protein 2 (MAP2; 1:1,000) and glial fibrillary acidic protein (GFAP; 
1:500) were also obtained from Abcam (ab28032, ab10062).The 
anti-Thy1.1 mouse monoclonal antibody (Millipore, MAB1406) 
was used at a concentration of 1:400. Brevican antiserum from 
guinea pig was used as described previously (John et al., 2006).
For Western blotting, horseradish peroxidase (HRP)-coupled 
secondary antibodies from the enhanced chemiluminescence sys-
tem (ECL; Amersham Biosciences) and the murine anti-rabbit 
IgG peroxidase-coupled antibody (Sigma, A-1949) were employed 
according to manufacturers’ protocols. For fluorescence micros-
copy, secondary antibodies conjugated to Alexa-488, Alexa-568, and 
Alexa-647 (Molecular Probes, A11073, A11035, A21236, A11031) 
were used at a concentration of 1:1,000.
Table 1 | Primers for cloning and mutagenesis.
  Forward-primer, reverse-primer  TA
Cloning (first PCR)  cCOMT-out-f: CCTGCTCAGAGGTGCTTTGAAG  52
  cCOMT-out-r: TCAGTACCAGGCTGGGTGAGA 
Cloning (second PCR)  cMB-COMT-f: AAGAATTCAGATGCCGGAGGCCCCGCCTCTG  58
  cS-COMT-f: AAGAATCCTCATGGGTGACACCAAGGAGCAG 
  cCOMT-r: ATGGATCCGCGGGCCCTGCTTCGCTGCCTGG 
Mutagenesis M51A  cCOMT51Ala-f: CAACCTGCTCGCGGGTGACACCAAGG  58
  cCOMT51Ala-r: CCTTGGTGTCACCCGCGAGCAGGTTG 
Mutagenesis M51V  cCOMT51Val-f: CAACCTGCTCGTGGGTGACACCAAGG  58
  cCOMT51Val-r: CCTTGGTGTCACCCACGAGCAGGTTG 
TA: annealing temperature (°C).www.frontiersin.org  October 2010  | Volume 1  | Article 142  |  3
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(3× in 1× PBS), coverslips were mounted in Mowiol (Hoechst). 
For staining of fixed cells, incubation with the primary antibody 
was performed after the blocking/permeabilization step at RT for 
30–60 min, with digitonin or 0.1% Triton X-100. All other steps 
were performed as described above. An antibody directed against 
the extracellular matrix proteoglycan Brevican was used as positive 
control to verify the live staining procedure of untransfected cells 
(Frischknecht et al., 2009).
Immunocytochemistry of COMT-GFP-transfected cells
We performed immunostainings for GFP on the transfected cells 
as live stainings, with or without permeabilization of membranes 
using digitonin, as described above. Additional stainings of per-
meabilized cells were performed after blocking/permeabilization 
with PFA (see above for details).
For live staining at DIV 8–12, 24–48 h after transfection, cells 
seeded on cover slips were incubated with the primary antibodies, 
diluted in NBM, under CO2 at 37°C for 15 min. To permeabilize cell 
membranes, digitonin solution was added to a final concentration 
of 10–15 μg/ml. After live staining, cells were fixed with ice-cold 
4% PFA and 4% sucrose.
Cells  were  examined  under  a  Zeiss Axioplan  2  microscope 
equipped with a SpotRT cooled CCD camera or a Leica DM-RXE 
fluorescence microscope, using the Spot software. Surface expres-
sion of COMT and NrCAM was quantified using ImageJ (National 
Institutes of Health, Bethesda, MD, USA). For the profile plot, fluo-
rescence intensities were measured along a line with diameter of 
500 nm using ImageJ.
statIstIcal analysIs
To compare fluorescence intensity of live-stained, unpermeabilized 
and fixed, permeabilized cells statistically, we computed the aver-
age fluorescence intensities of independent cells (N = 8 per group 
for endogenous COMT; N = 6 per group for cells overexpressed 
COMT-GFP fusion constructs; N = 5 per group for overexpressed 
COMT-NrCAM fusion constructs).
Statistical analysis was carried out using the algorithms imple-
mented in VassarStats (http://faculty.vassar.edu/lowry/VassarStats.
html).  To  quantify  fluorescence  of  cells  stained  against  native 
COMT, the raw mean gray values (arbitrary units) of live-stained 
cells and fixed cells were compared to those of cells stained with 
secondary antibody only, using a one-way ANOVA with the fac-
tor treatment (fixed, live, no primary). Antibody fluorescence of 
overexpressed COMT and NrCAM was normalized to the GFP 
autofluorescence of the fusion constructs, and the relative anti-
body fluorescence was compared using a two-way ANOVA with 
the factors construct (COMT-GFP, NrCAM-GFP) and treatment 
(live, fixed). ANOVAs were followed by post hoc T-test to verify 
directionality of the effects.
results
exPressIon of natIve coMt In neurons and GlIal cells
Co-staining with antibodies against COMT and MAP2 or GFAP 
showed that COMT immunoreactivity was reliably detectable in 
both, cultured cortical neurons (Figures 1C,D,G,H) and glial cells 
(Figures 1K,L,O,P). In fixed and permeabilized MAP2-positive neu-
rons, the COMT signal appears concentrated in the soma at   perinuclear 
PrIMary neuronal cultures
Animal handling and preparation of neuronal cell cultures were 
carried out in accordance with the guidelines of the Committee 
for Animal Protection of the Leibniz Institute for Neurobiology, 
Magdeburg. Preparation of cortical neurons was performed as 
described  previously  (Banker  and  Goslin,  1988),  with  minor 
modifications.  Brains  from  embryonic  rats  (E16  for  transfec-
tions, E18 for native immunocytochemistry) were prepared under 
Hank’s balanced salt solution (HBSS; +Ca2+, Mg2+), and the cor-
tex (excluding the olfactory bulb) was dissected, washed in HBSS 
(–Ca2+, Mg2+) and incubated in HBSS containing trypsin for 5 min 
(37°C). After trypsin removal cells were carefully dispersed under 
DMEM cell culture medium (10% fetal calf serum [FCS], 1 mM 
Na-Pyruvate, 1 mM Gln), and the cell suspension was diluted to 
a density of 1,500 cells/μl and seeded onto poly-d-lysine-coated 
18 mm cover slips. After 24 h, DMEM was replaced by neurobasal 
medium (NBM), containing 1× B27, 1 mM sodium pyruvate, 1× 
Albumax and penicillin and streptomycin as antibiotics. Medium 
for transfected cells additionally contained cytosine arabinoside 
(AraC, final concentration 15 μM), to limit excessive glial cell 
proliferation.
For Western blot analysis of COMT expression in neurons and 
glial cells, 250,000 rat cortical neurons prepared from E16-18 rats 
were plated in a 3-cm culture dish and cultured for 21 days. Glial 
cells were prepared from brains of rat pups on postnatal day 2 and 
grown in 3 cm culture dishes until confluence. Cell lysates were 
prepared by incubation of the cultures in 500 ml HBSS containing 
1% Triton X-100 and 1% SDS at 4°C for 15 min.
Transfection of neurons with expression vectors containing 
COMT-GFP fusion constructs was performed on days 7–10 in vitro 
(DIV  7–10)  using  the  Effectene  transfection  reagent  (Qiagen, 
Chatsworth, CA) according to the manufacturer’s protocol. No later 
than 12 h after transfection, the medium was replaced with fresh 
NBM. An additional population of cells was transfected with a pre-
viously described construct of GFP integrated into the extracellular 
portion of the NgCAM-related cell adhesion molecule NrCAM 
(NrCAM-GFP, Thoumine et al., 2005), using the same transfection 
protocol. The NrCAM-GFP construct served as a positive control 
for live staining of unpermeabilized cells.
IMMunocytocheMIcal Procedures
COS7 cells were grown on poly-d-lysine-coated coverslips, and 
membrane orientation was tested using immunocytochemistry, 
as described below, with minor modifications (i.e., permeabiliza-
tion of COS7 cells was performed using methanol/acetone instead 
of digitonin).
Immunocytochemistry of endogenous COMT
For live staining, cells at DIV 16–23 were incubated with the 
primary antibodies at 37°C for 15 min. Digitonin (final concen-
tration: 5 μg/ml for neurons, 30 μg/ml for glial cells) was used 
for permeabilization of cell membranes. Cells were then fixed 
(4% paraformaldehyde [PFA] for 10 min at room temperature 
[RT]), washed three times in 1× PBS and blocked with 10% horse 
serum + 25 mM glycine for 60 min. After blocking, cells were briefly 
rinsed (1× PBS) and incubated with the secondary antibodies in 
5% horse serum at RT for 60 min. Following a further washing step Frontiers in Psychiatry  |  Molecular Psychiatry    October 2010  | Volume 1  | Article 142  |  4
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sites, but is also present in dendrites (Figure 1D). Similarly, after 
fixation, GFAP-positive astroglia exhibited reliable COMT immu-
noreactivity with a filamentous appearance (Figure 1L).
To obtain first information about intra- vs. extracellular locali-
zation of the COMT epitopes, live staining of permeabilized and 
unpermeabilized cells was performed. Immunocytochemistry on 
living cells did not yield a staining above background neither in 
neurons nor in glial cells (Figures 1A,B,I,J). Only after membrane 
permeabilization, specific COMT immunoreactivity was detected 
suggesting an intracellular localization of the epitopes (compare 
Figure 1B vs. Figures 1C,D,J vs. Figures 1K,L). The feasibility of 
the live staining procedure on unpermeabilized cells was confirmed 
by live staining of cultured cells with an antibody against the extra-
cellular matrix proteoglycan Brevican, which revealed the typical 
perineuronal distribution of Brevican immunoreactivity described 
previously (data not shown, see John et al., 2006; Frischknecht et al., 
2009). The detectability of marker proteins GFAP or MAP2 pro- The detectability of marker proteins GFAP or MAP2 pro-
ves the unpermeabilized (Figures 1F,N) or permeabilized (Figures 
1G,H,O,P) state of the cells, with unpermeabilized cells showing 
only background fluorescence (Figures 1E,M).
We  next  quantified  fluorescence  intensities  of  live-stained 
unpermeabilized and fixed permeabilized neurons as compared 
to  neurons  stained  with  secondary,  but  no  primary  antibody 
(N = 8 cells per group). A one-way ANOVA revealed a significant 
between-group difference (F2,21 = 80.41, p < 0.0001), and post hoc 
T-tests confirmed that fluorescence of live-stained cells did not 
differ from the background fluorescence of cells treated without 
primary antibody, while both exhibited significantly lower fluo-
rescence than permeabilized cells (live > no primary: T14 = 0.56; 
p = 0.292; fixed > live: T14 = 9.19, p < 0.0001; fixed > no primary: 
T14 = 9.46, p < 0.0001; see Figure 1Q).
To obtain a more detailed view of the cellular distribution of 
COMT, cortical neurons were first subjected to live staining against 
Thy-1, a GPI-anchored surface protein from the Ig-superfamily, 
and  then  fixed,  permeabilized  and  stained  against  COMT 
(Figures 2A–D). A profile plot through a dendritic branch showed 
two peaks in Thy-1 fluorescence, representing Thy-1-labeling at 
the extracellular side of the plasma membrane (Figures 2D,E). 
Similarly, two lateral peaks of increased COMT fluorescence were 
observed near the plasma membrane. These were, however, slightly 
Figure 1 | Detection of endogenous COMT in primary cortical neurons 
and glial cells at DiV 23 under permeabilized or non-permeabilized 
conditions. (A–D,i–L) Staining for COMT. (e–H) Co-stainings with an antibody 
against the neuronal marker MAP2. (M–P) Co-stainings with an antibody against 
the glial marker GFAP . (A,e,i,M) Controls without primary antibody. (B,F,J,N) 
Neurons and glial cells stained live for COMT immunoreactivity. (C,g,K,O) 
Neurons and glial cells stained live for COMT immunoreactivity after 
permeabilization. (D,H,L,P) Neurons and glial cells stained for COMT 
immunoreactivity after fixation and permeabilization. Size bars denote 20 μm. 
(Q) Statistical comparison of fluorescence intensity showed a significant 
difference between fixed, permeabilized cells and live-stained, unpermeabilized 
cells, while the latter did not differ from background fluorescence (no primary).www.frontiersin.org  October 2010  | Volume 1  | Article 142  |  5
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MB-COMT (Figure 4A). To avoid co-expression of S-COMT-GFP, 
the Met codon at position 51 was mutated to Ala or Val (Ulmanen 
et al., 1997).
All COMT-GFP fusion constructs could be reliably expressed in 
COS7 cells (Figure 4B) as indexed by GFP autofluorescence. Western 
blotting of homogenized COS7 cells revealed that the mutagenesis at 
amino acid position 51 led to an exclusive expression of MB-COMT-
GFP in absence of S-COMT-GFP (Figure 4C), and the protein frac-
tionation analysis further showed that both MB-COMT-Ala and 
MB-COMT-Val were mostly localized to membranous compart-
ments of COS7 cells (Figure 4D) indicating correct intracellular 
processing of the mutated chimeric proteins.
MeMbrane orIentatIon of coMt-GfP fusIon constructs
The cellular localization of the COMT-GFP fusion protein was 
first investigated in COS7 cells. Cells permeabilized with methanol/
acetone showed basically an exact overlap of antibody fluorescence 
with the autofluorescence of the GFP fusion constructs. After live 
staining of unpermeabilized cells, no specific antibody fluorescence 
was detectable, and there was consequently no relevant overlap of 
antibody fluorescence and GFP autofluorescence (data not shown). 
This finding is in agreement with previously reported intracel-
lular orientation of MB-COMT in non-neuronal cells (Ulmanen 
et al., 1997).
As functionality of cellular sorting signals and membrane topol-
ogy might be cell-type specific and different in cells endogenously or 
heterologously expressing COMT, we investigated the possibility of a 
potential neuron-specific extracellular orientation of MB-COMT. To 
shifted toward the intracellular compartment, suggesting localiza-
tion of COMT epitopes at the intracellular side of the plasma mem-
brane (Figures 2D,E). Furthermore, diffuse staining was found 
within the dendrite, most likely due to the presence of S-COMT and 
MB-COMT at intracellular membranes (Karhunen et al., 1995a,b; 
Ulmanen et al., 1997).
Because the antibody recognizes both, S-COMT and MB-COMT 
signals, the immunostainings do not provide information about 
potentially differential expression of the isoforms in neurons or 
glial cells. We therefore employed Western blot analyses to inves-
tigate potentially dissociable expression patterns of COMT iso-
forms in neurons and glia. Western blotting revealed predominant 
expression of MB-COMT in neurons and similar amounts of 
S-COMT and MB-COMT in glial cells (Figure 3). Furthermore, 
a larger COMT-immunoreactive band was observed in both cell 
types and in brain homogenate at approximately 39 kDa, probably 
representing a novel COMT isoform (Tunbridge et al., 2006b). 
In the brain extract, several smaller immunoreactive bands were 
detected with the antibody, possibly reflecting partially degraded 
COMT protein.
MeMbranous localIzatIon of Mutated Mb-coMt-GfP fusIon 
constructs
To circumvent the obstacle that the polyclonal antibodies against 
COMT might potentially be not suitable for live detection of the 
native antigen, we performed co-localization studies of COMT-
GFP autofluorescence and antibody fluorescence of immunos-
taining against the GFP epitope fused to the C-terminal end of 
Figure 2 | Catechol-O-methyl transferase staining is enriched in the 
vicinity of the neuronal membrane. Dissociated cortical neurons at DIV21 
stained with an anti-COMT antibody after permeabilization (A). Strongest 
immunofluorescence was found in the cell body. Staining in the dendrites had 
diffuse and dot-like appearance. Live staining against Thy-1 was used to label 
the neuronal surface (B), which did hardly overlap with COMT as seen in the 
overlay (C) or the high magnification image of the dendritic segment boxed in 
(C). (D) In order to analyze COMT distribution in more detail we performed a 
profile plot through a dendritic segment. The dotted line in (D) represents the 
position of the profile plot shown in (e). For Thy-1 (red line), two peaks in 
fluorescence were found representing the outer boundary of the neuronal 
membrane. Similarly, two peaks were found for COMT fluorescence (green 
line), also pointing toward a plasma membrane association of COMT. However, 
the fluorescence is slightly shifted toward the cytoplasm indicating, as 
expected, an intracellular localization of COMT epitopes (scale bars: 10 μm in C, 
2 μm in D).Frontiers in Psychiatry  |  Molecular Psychiatry    October 2010  | Volume 1  | Article 142  |  6
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dIscussIon
The intracellular localization and orientation of MB-COMT in 
neurons and glial cells is critical for the understanding of the precise 
mechanism by which COMT influences dopamine availability in 
brain structures with low dopamine transporter activity.
Building on previous studies showing the presence of COMT 
at postsynaptic membranes (Karhunen et al., 1995b) and the 
intracellular localization of COMT epitopes in non-neuronal 
cells (Ulmanen et al., 1997), our present immunocytochemical 
localization studies of native neuronal and glial COMT and of 
GFP-fused MB-COMT in primary neural cell cultures provide 
converging evidence for an intracellular orientation of neural 
MB-COMT. Profile plot revealed that COMT immunoreactivity 
did peak at dendritic plasma membranes, but was shifted intra-
cellularly relative to the – known extracellular – fluorescence of 
the Thy-1 epitope. In our overexpression experiments, the GFP 
moiety was fused to the C-terminus of MB-COMT, distal to the 
putative transmembrane domain and had thus the same mem-
brane orientation as the catalytic domain. One potential caveat 
might be that the inverse approach, fusing GFP to the N-terminus 
of MB-COMT was attempted, but the resulting construct formed 
aggregates  and  exerted  cytotoxic  effects.  It  should  be  noted, 
though, that such an outcome was not unexpected, as fusing the 
relatively large GFP to the small N-terminus (six amino acids) 
was quite likely to profoundly affect posttranslational intracel-
lular processing of the protein in an unpredictable fashion. On 
the other hand, such effects would be much less expected when 
fusing the GFP tag to the C-terminus. Extracellular action of 
neuronal or glial MB-COMT is thus unlikely to contribute to 
metabolization of dopamine under conditions of DAT1 inhibition 
or sparse DAT1 expression. Our results do not exclude a potential 
extracellular orientation of other COMT isoforms that have not 
been characterized on protein level, but might indeed exist, based 
both on Western blot analyses (Tunbridge et al., 2006b) and on 
mRNA expression studies of novel putative COMT splice variants 
(Tunbridge et al., 2007). It should be noted, though, that COMT 
isoforms resulting from these mRNAs should be recognized by 
the COMT antibodies used here and thus be detected by our 
immunocytochemical investigations, assuming they are consti-
tutively expressed. And indeed we could replicate the previously 
observed larger COMT isoform at 39 kDa, which was observed 
in both neurons and glial cells, although more reliably in neu-
rons. As pointed out by Tunbridge et al. (2006b), this band most 
likely reflects the authentic COMT enzyme, as it was absent in 
COMT knockout mice. This interpretation is not in disagreement 
with the absence of a corresponding band in the Western blot of 
overexpressed COMT (Figures 4C,D), as only the open reading 
frame of the known MB-COMT was cloned. However, while we 
were able to confirm the presence of this novel COMT isoform, 
we still detected no COMT immunoreactivity during live staining 
of unpermeabilized cortical neurons and glial cells. Therefore, any 
potentially extracellularly active COMT isoforms would have to 
be expressed at very low levels or orientated to the extracellular 
space in a transient, possibly activity-dependent,manner. 
An  alternative  explanation  for  the  apparent  discrep-
ancy  between  intracellular  orientation  of  MB-COMT  and 
the   well-documented  role  of  COMT  for  DAT1-independent 
this end, embryonal cortex neurons from rats (E16) were transfected 
with the COMT-GFP construct at DIV 7–10. We immunostained 
transfected neurons either live, with or without permeabilization by 
digitonin, or fixed and permeabilized with Triton X-100. Neurons 
transfected with a GFP fusion construct of the cell-surface adhesion 
molecule NrCAM were used as positive controls for live staining 
of an extracellular GFP epitope. As expected, the control neurons 
transfected  with  NrCAM-GFP  showed  reliable  overlap  of  GFP 
autofluorescence and antibody fluorescence with and without per-
meabilization. In contrast, overlap of COMT-GFP autofluorescence 
and antibody fluorescence was detectable only after permeabilization 
of the cells, providing further evidence for intracellular orientation 
of MB-COMT in neurons (Figure 5A). For statistical comparison, 
the antibody fluorescence intensity of fixed permeabilized and live-
stained unpermeabilized cells was normalized to the GFP autofluo-
rescence. We performed a two-way ANOVA with construct (COMT 
[N = 2 × 6] vs. NrCAM [N = 2 × 5]) and treatment (fixed permea-
bilized vs. live unpermeabilized) as factors. There was a significant 
main effect of treatment (F1,1,18 = 54.76, p < 0.0001), reflecting overall 
stronger antibody fluorescence for fixed cells, and a significant con-
struct by treatment interaction (F1,1,18 = 12.27, p = 0.0025), reflect-
ing a significant difference in antibody fluorescence for COMT vs. 
NrCAM in unpermeabilized, but not in fixed cells. This difference 
was confirmed by a post hoc T-test (COMT < NrCAM: T9 = −5.34, 
p = 0.0002; see Figure 5B).
Figure 3 | Discrimination of COMT isoforms in Western blotting. In the 
mouse forebrain homogenate (H) and in cultured glial cells (G), MB-COMT and 
S-COMT were expressed at similar levels, while MB-COMT was the 
predominant isoform in cultured cortical neurons at DIV 21 (N). MB, 
MB-COMT; S, S-COMT; the asterisk (*) denotes a b and most likely 
corresponding to a previously described novel COMT isoform (Tunbridge et al., 
2006b). Note that the exposition time of the blot was adjusted to visualize the 
faint bands in the neuronal culture (N), which leads to overexposition of strong 
bands in the homogenate and the glial culture lanes (H, G).www.frontiersin.org  October 2010  | Volume 1  | Article 142  |  7
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family. PMAT has recently been shown to be highly expressed in 
both human and rodent forebrain cortex (Engel et al., 2004; Dahlin 
et al., 2007), including brain regions with sparse DAT1 expression. 
As there is to date no direct functional evidence that PMAT medi-
ates DAT1-independent dopamine uptake in brain regions such as 
the PFC, future research needs to determine the functionality of 
PMAT in the human brain and a potential role in the pathogenesis 
of neurological and psychiatric disorders.
An  extraneuronal  monoamine  transporter  (EMT)  has  also 
been described. While EMT might in principle be able to transport 
dopamine into glial cells, where it could be metabolized via the 
COMT pathway, EMT expression has thus far only been detected 
in the area postrema of the brainstem (Haag et al., 2004), making a 
quantitative contribution of EMT to DAT1-independent dopamine 
inactivation in the PFC unlikely.
It has previously been suggested that in the PFC slower dopamine 
inactivation by COMT leads to a more extensive extracellular dif-
fusion of dopamine as compared to the striatum and thus to local 
spreading of dopamine action (Bilder et al., 2004; Goto and Grace, 
2007). While this model has previously been based on assumed 
dopamine inactivation would be the presence of additional 
uptake mechanisms. COMT is expressed in high concentration 
in the postsynaptic region of dendritic spines, suggesting the 
presence of a postsynaptic transporter molecule (Karhunen 
et al., 1995a) that might be responsible for dopamine reuptake, 
which could then be followed by COMT-dependent metaboliza-
tion. In the PFC, dopamine can in principle be taken up by the 
norepinephrine transporter (NET), particularly when DAT1 is 
inhibited (Tanda et al., 1997; Mazei et al., 2002). However, the 
quantitative role of NET in dopamine uptake is under debate 
(Wayment et al., 2001). Because NET is, similar to DAT1, pri-
marily expressed presynaptically (Bönisch and Brüss, 2006), 
NET-dependent dopamine uptake is unlikely to explain the 
high proportion of COMT-dependent dopamine metabolites 
under conditions of DAT1 inhibition.
A potential candidate transporter protein responsible for post-
synaptic dopamine uptake might be the recently described plasma 
membrane monoamine transporter (PMAT; NCBI accession # 
NM_153247),  a  low-affinity,  high-capacity  monoamine  trans-
porter  with  structural  similarity  to  the  nucleoside  transporter 
Figure 4 | generation of mutated COMT-gFP fusion constructs. 
(A) Schematic illustration of the COMT-GFP fusion protein. The mutation site of 
the S-COMT start codon at Met51 is indicated. TM, putative transmembrane 
domain; COMT, catalytic region, present in both S- and MB-COMT; GFP , green 
fluorescent protein fused to the C terminus. (B) Autofluorescence of the 
COMT-GFP fusion constructs in COS7 cells. (C) Western blot of COS7 cell 
homogenates, using a murine αGFP antibody. (D) Western blot of fractionated 
COS7 cell homogenates using the same antibody. S, soluble COMT; WT, 
wild-type MB-COMT; M51A, methionine–alanine substitution in MB-COMT; 
M51V, methionine–valine substitution in MB-COMT.Frontiers in Psychiatry  |  Molecular Psychiatry    October 2010  | Volume 1  | Article 142  |  8
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Figure 5 |  (A) Expression of MB-COMT-GFP fusion constructs in cortical neurons 
at DIV 12. Left column: fluorescence of the antibody directed against GFP fused to 
the C terminus of mutated MB-COMT (MB-COMT M51A). Middle column: 
autofluorescence of the GFP tag. Right column: merge of autofluorescence and 
antibody fluorescence. Rows: 3,4 Control stainings of GFP-NrCAM-transfected 
neurons indicate that the GFP antibody is capable of detecting the native GFP 
epitope when expressed extracellularly. Rows 2, 4: neurons permeabilized with 
digitonin. Rows 1, 3: unpermeabilized neurons. Row 5: control without primary 
antibody. Size bars denote 20 μm. (B) Statistical comparison yielded a significant 
difference between live-stained, unpermeabilized COMT- and NrCAM-transfected 
neurons, but not after staining of fixed, permeabilized cells. The y-axis displays the 
normalized fluorescence intensity (antibody fluorescence/GFP autofluorescence).
extracellular action of COMT (Bilder et al., 2004), our current 
findings are not incompatible with this view. Regulation of synaptic 
vs. extrasynaptic localization of PMAT might, for example, provide 
a cellular mechanism that could modulate the extent of dopamine 
diffusion in brain regions with low DAT1 expression.
In summary, our results show that the catalytic domain of 
MB-COMT is orientated toward the intracellular space, warrant-
ing further investigation of DAT1-independent dopamine uptake 
mechanisms in postsynaptic neurons and glial cells and the possible 
existence of other COMT isoforms that might act extracellularly.
acknowledGMents
We thank Olivier Thoumine, Julien Falk, and Martin Heine for 
providing the NrCAM-GFP construct and Sabine Opitz, Monika 
Marunde, Heidi Wickborn, and Maria Michelmann for expert 
technical assistance. The authors gratefully acknowledge financial 
support by the Deutsche Forschungsgemeinschaft (DFG SFB 779, 
TP A8 & B9 to Björn H. Schott, Constanze I. Seidenbecher, and 
Eckart D. Gundelfinger, and DFG Gu230/5-2, 3 to Constanze I. 
Seidenbecher, Renato Frischknecht, and Eckart D. Gundelfinger), 
and the Helmholtz Gemeinschaft (VH-VI-125).www.frontiersin.org  October 2010  | Volume 1  | Article 142  |  9
Schott et al.  Intracellular orientation of neuronal COMT
Tunbridge,  E.  M.,  Weinberger,  D. 
R., and Harrison P. J. (2006b). A 
novel protein isoform of catechol 
O-methyltransferase (COMT): brain 
expression analysis in schizophrenia 
and bipolar disorder and effect of 
Val158Met genotype. Mol. Psychiatry 
11, 116–117.
Tunbridge, E. M., Lane, T. A., and Harrison, 
P. J. (2007). Expression of multiple cat-
echol-o-methyltransferase (COMT) 
mRNA variants in human brain. Am. 
J. Med. Genet. B Neuropsychiatr. Genet. 
144, 834–839.
Ulmanen, I., Peranen, J., Tenhunen, J., 
Tilgmann, C., Karhunen, T., Panula, 
P., Bernasconi, L., Aubry, J. P., and 
Lundstrom, K. (1997). Expression and 
intracellular localization of catechol 
O-methyltransferase in transfected 
mammalian cells. Eur. J. Biochem. 
243, 452–459.
Wayment, H. K., Schenk, J. O., and Sorg, 
B. A. (2001). Characterization of 
extracellular dopamine clearance in 
the medial prefrontal cortex: role of 
monoamine uptake and monoamine 
oxidase inhibition. J. Neurosci. 21, 
35–44.
Williams,  H.  J.,  Owen,  M.  J.,  and 
O’Donovan, M. C. (2007). Is COMT 
a susceptibility gene for schizophrenia? 
Schizophr. Bull. 33, 635–641.
Conflict of Interest Statement:  The 
authors declare that the research was con-
ducted in the absence of any commercial or 
financial relationships that could be con-
strued as a potential conflict of interest.
Received: 02 July 2010; accepted: 29 
September 2010; published: 28 October 
2010.
Citation: Schott BH, Frischknecht R, 
Debska-Vielhaber G, John N, Behnisch G, 
Düzel E, Gundelfinger ED and Seidenbecher 
CI (2010) Membrane-bound catechol-
O-methyl transferase in cortical neurons 
and glial cells is intracellularly oriented. 
Front. Psychiatry 1:142. doi: 10.3389/
fpsyt.2010.00142
This article was submitted to Frontiers 
in Molecular Psychiatry, a specialty of 
Frontiers in Psychiatry.
Copy right © 2010 Schott, Frischknecht, 
Debska-Vielhaber, John, Behnisch, Düzel, 
Gundelfinger and Seidenbecher. This is an 
open-access article subject to an exclusive 
license agreement between the authors 
and the Frontiers Research Foundation, 
which permits unrestricted use, distribu-
tion, and reproduction in any medium, 
provided the original authors and source 
are credited.
brain by membrane-bound and sol-
uble catechol-o-methyltransferase 
(COMT)  estimated  by  enzyme 
kinetic values. Med. Hypotheses 57, 
628–632.
Rivett, A. J., Francis, A., and Roth, J. A. 
(1983a). Localization of membrane-
bound catechol-O-methyltransferase. 
J. Neurochem. 40, 1494–1496.
Rivett, A. J., Francis, A., and Roth, J. A. 
(1983b). Distinct cellular localization 
of membrane-bound and soluble 
forms of catechol-O-methyltrans-
ferase in brain. J. Neurochem. 40, 
215–219.
Schott, B. H., Seidenbecher, C. I., Fenker, 
D. B., Lauer, C. J., Bunzeck, N., 
Bernstein, H. G., Tischmeyer, W., 
Gundelfinger, E. D., Heinze, H. J., and 
Düzel, E. (2006). The dopaminergic 
midbrain participates in human epi-
sodic memory formation: evidence 
from genetic imaging. J. Neurosci. 26, 
1407–1417.
Seidenbecher, C. I., Smalla, K. H., Fischer, 
N., Gundelfinger, E. D., and Kreutz, M. 
R. (2002). Brevican isoforms associate 
with neural membranes. J. Neurochem. 
83, 738–746.
Sesack, S. R., Hawrylak, V. A., Matus, C., 
Guido, M. A., and Levey, A. I. (1998). 
Dopamine axon varicosities in the 
prelimbic division of the rat prefron-
tal cortex exhibit sparse immunoreac-
tivity for the dopamine transporter. J. 
Neurosci. 18, 2697–2708.
Tan, H. Y., Chen, Q., Goldberg, T. E., 
Mattay, V. S., Meyer-Lindenberg, A., 
Weinberger, D. R., and Callicott, J. H. 
(2007). Catechol-O-methyltransferase 
Val158Met modulation of prefrontal–
parietal–striatal brain systems during 
arithmetic and temporal transforma-
tions in working memory. J. Neurosci. 
27, 13393–13401.
Tanda, G., Pontieri, F. E., Frau, R., and 
Di Chiara, G. (1997). Contribution 
of blockade of the noradrenaline car-
rier to the increase of extracellular 
dopamine in the rat prefrontal cortex 
by amphetamine and cocaine. Eur. J. 
Neurosci. 9, 2077–2085.
Thoumine, O., Saint-Michel, E., Dequidt, 
C., Falk, J., Rudge, R., Galli, T., Faivre-
Sarrailh, C., and Choquet, D. (2005). 
Weak effect of membrane diffusion 
on the rate of receptor accumulation 
at adhesive contacts. Biophys. J. 89, 
L40–L42.
Tunbridge, E. M., Harrison, P. J., and 
Weinberger, D. R. (2006a). Catechol-
o-methyltransferase, cognition, and 
psychosis: Val158Met and beyond. 
Biol. Psychiatry 60, 141–151.
Goto, Y., and Grace, A. A. (2007). The 
dopamine system and the patho-
physiology of schizophrenia: a basic 
science perspective. Int. Rev. Neurobiol. 
78C, 41–68.
Haag, C., Berkels, R., Grundemann, D., 
Lazar, A., Taubert, D., and Schomig, 
E. (2004). The localisation of the 
extraneuronal monoamine transporter 
(EMT) in rat brain. J. Neurochem. 88, 
291–297.
Huotari,  M.,  Gainetdinov,  R.,  and 
Männistö, P. T. (1999). Microdialysis 
studies on the action of tolcapone on 
pharmacologically-elevated extracel-
lular dopamine levels in conscious 
rats. Pharmacol. Toxicol. 85, 233–238.
John, N., Krügel, H., Frischknecht, R., 
Smalla, K. H., Schultz, C., Kreutz, M. R., 
Gundelfinger, E. D., and Seidenbecher, 
C. I. (2006). Brevican-containing 
perineuronal nets of extracellular 
matrix in dissociated hippocampal 
primary cultures. Mol. Cell. Neurosci. 
31, 774–784.
Karhunen, T., Tilgmann, C., Ulmanen, 
I., and Panula, P. (1995a). Neuronal 
and non-neuronal catechol-O-meth-
yltransferase in primary cultures of 
rat brain cells. Int. J. Dev. Neurosci. 
13, 825–834.
Karhunen, T., Tilgmann, C., Ulmanen, 
I., and Panula, P. (1995b). Catechol-
O-methyltransferase (COMT) in rat 
brain: immunoelectron microscopic 
study with an antiserum against rat 
recombinant COMT protein. Neurosci. 
Lett. 187, 57–60.
Karoum, F., Chrapusta, S. J., and Egan, 
M. F. (1994). 3-Methoxytyramine 
is the major metabolite of released 
dopamine in the rat frontal cortex: 
reassessment of the effects of antipsy-
chotics on the dynamics of dopamine 
release and metabolism in the frontal 
cortex, nucleus accumbens, and stria-
tum by a simple two pool model. J. 
Neurochem. 63, 972–979.
Matsumoto, M., Weickert, C. S., Akil, 
M.,  Lipska,  B.  K.,  Hyde,  T.  M., 
Herman, M. M., Kleinman, J. E., and 
Weinberger, D. R. (2003). Catechol 
O-methyltransferase mRNA expres-
sion in human and rat brain: evidence 
for a role in cortical neuronal function. 
Neuroscience 116, 127–137.
Mazei, M. S., Pluto, C. P., Kirkbride, B., 
and Pehek, E. A. (2002). Effects of 
catecholamine uptake blockers in the 
caudate-putamen and subregions of 
the medial prefrontal cortex of the rat. 
Brain Res. 936, 58–67.
Reenilä, I., and Männistö, P. T. (2001). 
Catecholamine metabolism in the 
references
Banker,  G.,  and  Goslin,  K.  (1988). 
Developments in neuronal cell culture. 
Nature 336, 185–186.
Bilder, R. M., Volavka, J., Lachman, H. M., 
and Grace A. A. (2004). The catechol-
O-methyltransferase polymorphism: 
relations to the tonic-phasic dopamine 
hypothesis and neuropsychiatric phe-
notypes. Neuropsychopharmacology 
29, 1943–1961.
Bonisch, H., and Bruss, M. (2006). 
The norepinephrine transporter in 
physiology and disease. Handb. Exp. 
Pharmacol. 175, 485–524.
Chen, J., Lipska, B. K., Halim, N., Ma, 
Q. D., Matsumoto, M., Melhem, S., 
Kolachana, B. S., Hyde, T. M., Herman, 
M. M., Apud, J., Egan, M. F., Kleinman, 
J. E., and Weinberger D. R. (2004). 
Functional analysis of genetic varia-
tion in catechol-O-methyltransferase 
(COMT): effects on mRNA, protein, 
and enzyme activity in postmortem 
human brain. Am. J. Hum. Genet. 75, 
807–821.
Dahlin, A., Xia, L., Kong, W., Hevner, R., 
and Wang J. (2007). Expression and 
immunolocalization of the plasma 
membrane monoamine transporter 
in  the  brain.  Neuroscience  146, 
1193–1211.
Diaz-Asper, C. M., Goldberg, T. E., 
Kolachana, B. S., Straub, R. E., Egan, 
M. F., and Weinberger D. R. (2008). 
Genetic variation in catechol-O-
methyltransferase: effects on work-
ing memory in schizophrenic patients, 
their siblings, and healthy controls. 
Biol. Psychiatry 63, 72–79.
Egan, M. F., Goldberg, T. E., Kolachana, 
B. S., Callicott, J. H., Mazzanti, C. 
M., Straub, R. E., Goldman, D., and 
Weinberger, D. R. (2001). Effect of 
COMT Val108/158 Met genotype 
on frontal lobe function and risk for 
schizophrenia. Proc. Natl. Acad. Sci. 
U.S.A. 98, 6917–6922.
Elofsson, A., and von Heijne, G. (2007). 
Membrane protein structure: predic-
tion versus reality. Annu. Rev. Biochem. 
76, 125–140.
Engel, K., Zhou, M., and Wang, J. (2004). 
Identification and characterization 
of a novel monoamine transporter in 
the human brain. J. Biol. Chem. 279, 
50042–50049.
Frischknecht, R., Heine, M., Perrais, D., 
Seidenbecher, C. I., Choquet, D., and 
Gundelfinger, E. D. (2009). Brain 
extracellular matrix affects AMPA 
receptor lateral mobility and short-
term synaptic plasticity. Nat. Neurosci. 
12, 897–904.